Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.ArcticDx Develops DNA Test For AMD Vision Loss
Screening for the genetic variation has been incorporated into a next-generation version of Macula Risk, ArcticDx’s DNA test that is intended as a prognostic test for patients who
Screening for the genetic variation has been incorporated into a next-generation version of Macula Risk, ArcticDx’s DNA test that is intended as a prognostic test for patients who
Earlier, Trappsol Cyclo was approved under compassionate use by the FDA in April 2009, to treat Addi and Cassi Hempel, identical twin girls suffering from NPC disease. Reportedly,
The investment is expected to enable Oval Medical to advance the development of its injection technology, including the production of new drug containers and prototype injection devices for
Most of Interbat’s business is manufacturing and sales of its own prescription and over the counter pharmaceuticals. The company is represented in 1200 of Indonesian hospitals. From a
The objective of the study was to assess a muco-adhesive lipid-based bioerodable patch as a novel device to decrease signs and symptoms associated with dry mouth, compared to
Retrospective testing of Rotarix, using new molecular detection techniques, has confirmed that material from PCV-1 has been present since the initial stages of the vaccine’s development in the
The granted claims of the patent, is valid until 2025, include the class of selective 5-HT compounds discovered by Suven and are being developed as therapeutic agents and
PhytoMedical said that in addition to his appointment as president and CEO, Mr Lynch will also serve on the company’s board of directors. Mr Lynch brings over two
The company said that the CE marking certifies that the two products have met the European Union (EU) health and safety standards and are approved for sale in
In a previously conducted Phase 1B, PMX-60056 demonstrated safety and efficacy in reversing heparin in healthy subjects. PMX-60056, one of PolyMedix’s lead compounds, is designed as a small